Prescription Drugs - Uganda

  • Uganda
  • In Uganda, the revenue in the Prescription Drugs market is estimated to reach US$173.10m by 2024.
  • It is projected to experience an annual growth rate (CAGR 2024-2029) of 5.03%, leading to a market volume of US$221.20m by 2029.
  • When comparing globally, United States is expected to generate the highest revenue in this market, with US$358.90bn in 2024.
  • In terms of per capita figures, each person in Uganda is estimated to generate a revenue of US$3.47 in 2024.
  • Uganda's prescription drug market is experiencing a surge in demand for affordable generic medications.

Key regions: Japan, China, Europe, Australia, Canada

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Prescription Drugs (Pharmacies) market in Uganda has been experiencing significant growth in recent years, driven by several factors. Customer preferences have shifted towards a greater reliance on pharmacies for their prescription drug needs, leading to increased demand for these services. Additionally, local special circumstances and underlying macroeconomic factors have also contributed to the development of the market.

Customer preferences:
Customers in Uganda have shown a growing preference for obtaining prescription drugs from pharmacies. This shift can be attributed to several factors. Firstly, pharmacies offer convenience and accessibility, with many located in urban areas and open for extended hours. This allows customers to easily access the medications they need without having to travel long distances or wait for appointments with healthcare providers. Secondly, pharmacies often provide a wide range of prescription drugs, giving customers more options and ensuring that they can find the specific medications they require. Finally, pharmacies are seen as trustworthy sources of medication, providing customers with the assurance that they are receiving genuine and safe products.

Trends in the market:
One of the key trends in the Prescription Drugs (Pharmacies) market in Uganda is the increasing number of pharmacies. This growth can be attributed to the rising demand for prescription drugs and the expanding healthcare infrastructure in the country. As the population grows and becomes more aware of the importance of proper healthcare, the demand for prescription drugs is expected to continue increasing. This, in turn, creates opportunities for new pharmacies to enter the market and cater to the growing customer base. Another trend in the market is the adoption of digital technologies by pharmacies. Many pharmacies in Uganda are now embracing online platforms and mobile apps to provide services such as online orders, home delivery, and virtual consultations. This trend is driven by the increasing use of smartphones and internet connectivity, allowing customers to access healthcare services more conveniently. The adoption of digital technologies also helps pharmacies streamline their operations, improve inventory management, and enhance customer experience.

Local special circumstances:
Uganda faces several local special circumstances that have influenced the development of the Prescription Drugs (Pharmacies) market. One of these is the high prevalence of infectious diseases, such as malaria and HIV/AIDS. These diseases require ongoing treatment and management, leading to a consistent demand for prescription drugs. Additionally, the country has a relatively young population, with a large percentage of the population under the age of 30. This demographic trend contributes to the demand for prescription drugs, as younger individuals may require medications for various health conditions.

Underlying macroeconomic factors:
Several underlying macroeconomic factors have also played a role in the development of the Prescription Drugs (Pharmacies) market in Uganda. The country has experienced steady economic growth in recent years, leading to an increase in disposable income and improved access to healthcare services. As a result, more individuals are able to afford prescription drugs and seek medical treatment when needed. Furthermore, government initiatives aimed at improving healthcare infrastructure and expanding access to healthcare services have also contributed to the growth of the market. These initiatives include the establishment of more health centers and the implementation of health insurance schemes, which help individuals afford the cost of prescription drugs.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)